Skip to main content
  • 976 Accesses

Abstract

Behçet disease (BD) is a multifactorial inflammatory disorder characterized by recurrent attacks affecting mucocutaneous and ocular tissues as well as joints, blood vessels, and central nervous and gastrointestinal systems. Although this distinct set of manifestations was first thought to be associated with a generalized viral infection, no specific causative agent could be isolated. But several microorganisms, including uncommon serotypes of streptococcal strains and herpes simplex virus, have been implicated as triggers of disease manifestations in genetically susceptible individuals, and a hypersensitivity to streptococcal antigens and a possible cross-reactivity with self-proteins have been suggested in the pathogenesis of BD. Genetic factors may play a role in susceptibility to certain microbial agents as well as in the hyper-reactive immune response to these pathogens and other dangerous insults. Identification of the genetic and immunologic basis of the disordered host—microbial interactions is expected to provide insights to reduce the impact of BD in the patients as well as in the high-risk populations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BD:

Behçet disease

HLA:

Human leukocyte antigen

HSP60:

Heat shock protein 60-kDa

HSP65:

Heat shock protein 65-kDa

ICR:

Institute of Cancer Research

References

  1. Gul A. Pathogenesis of Behcet’s disease: autoinflammatory features and beyond. Semin Immunopathol. 2015;37(4):413–8.

    Article  PubMed  Google Scholar 

  2. Behcet H. Über rezidivierende, apthöse durch ein Virus verursachte Geschwüre am Mund, am Auge und an der Genitalen. Dermatol Wochenschr. 1937;105:1152–7.

    Google Scholar 

  3. Behcet H, Matteson EL. On relapsing, aphthous ulcers of the mouth, eye and genitalia caused by a virus. 1937. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S2–5.

    PubMed  Google Scholar 

  4. Sezer FN. The isolation of a virus as the cause of Behcet’s diseases. Am J Ophthalmol. 1953;36(3):301–15.

    Article  CAS  PubMed  Google Scholar 

  5. Sezer N. Further investigations on the virus of Behcet’s disease. Am J Ophthalmol. 1956;41(1):41–55.

    Article  CAS  PubMed  Google Scholar 

  6. Eglin RP, Lehner T, Subak-Sharpe JH. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet’s syndrome and recurrent oral ulcers. Lancet. 1982;2(8312):1356–61.

    Article  CAS  PubMed  Google Scholar 

  7. Young C, Lehner T, Barnes CG. CD4 and CD8 cell responses to herpes simplex virus in Behcet’s disease. Clin Exp Immunol. 1988;73(1):6–10.

    PubMed Central  PubMed  CAS  Google Scholar 

  8. Davies UM, Palmer RG, Denman AM. Treatment with acyclovir does not affect orogenital ulcers in Behcet’s syndrome: a randomized double-blind trial. Br J Rheumatol. 1988;27(4):300–2.

    Article  CAS  PubMed  Google Scholar 

  9. Sohn S. Etiopathology of Behcet’s disease: herpes simplex virus infection and animal model. Yonsei Med J. 1997;38(6):359–64.

    Article  CAS  PubMed  Google Scholar 

  10. Sohn S, Lee ES, Bang D, Lee S. Behcet’s disease-like symptoms induced by the herpes simplex virus in ICR mice. Eur J Dermatol. 1998;8(1):21–3.

    CAS  PubMed  Google Scholar 

  11. Sohn S, Lee ES, Lee S. The correlation of MHC haplotype and development of Behcet’s disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci. 2001;26(3):173–81.

    Article  CAS  PubMed  Google Scholar 

  12. Buskila D, Gladman DD, Gilmore J, Salit IE. Behcet’s disease in a patient with immunodeficiency virus infection. Ann Rheum Dis. 1991;50(2):115–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  13. Kanazawa H, Ijichi S, Eiraku N, Igakura T, Higuchi I, Nakagawa M, et al. Behcet’s disease and Sjogren syndrome in a patient with HTLV-I-associated myelopathy. J Neurol Sci. 1993;119(1):121–2.

    Article  CAS  PubMed  Google Scholar 

  14. Park BM, Ahn JS, Lee JB, Won YH, Yun SJ. Chronic active Epstein-Barr virus infection-associated hydroa vacciniforme-like eruption and Behcet’s-like orogenital ulcers. Dermatology. 2013;226(3):212–6.

    Article  CAS  PubMed  Google Scholar 

  15. Annigeri RA, Rajagopalan M, Mani RM, Kaveripattu SS. Cytomegalovirus infection inducing flare of Behcet’s disease with possible recurrence of glomerulonephritis after renal transplantation. Indian J Nephrol. 2016;26(1):45–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Behcet H. Some observations on the clinical picture of the so-called triple symptom complex. Dermatologica. 1940;81:73–83.

    Article  Google Scholar 

  17. Mumcu G, Ergun T, Inanc N, Fresko I, Atalay T, Hayran O, et al. Oral health is impaired in Behcet’s disease and is associated with disease severity. Rheumatology (Oxford). 2004;43(8):1028–33.

    Article  CAS  Google Scholar 

  18. Kaneko F, Oyama N, Yanagihori H, Isogai E, Yokota K, Oguma K. The role of streptococcal hypersensitivity in the pathogenesis of Behcet’s disease. Eur J Dermatol. 2008;18(5):489–98.

    CAS  PubMed  Google Scholar 

  19. Kaneko F, Togashi A, Nomura E, Nakamura K. A new diagnostic way for Behcet’s disease: skin prick with self-saliva. Genet Res Int. 2014;2014:1–10.

    Google Scholar 

  20. Isogai E, Ohno S, Kotake S, Isogai H, Tsurumizu T, Fujii N, et al. Chemiluminescence of neutrophils from patients with Behcet’s disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol. 1990;35(1):43–8.

    Article  CAS  PubMed  Google Scholar 

  21. Yokota K, Hayashi S, Araki Y, Isogai E, Kotake S, Yoshikawa K, et al. Characterization of Streptococcus sanguis isolated from patients with Behcet’s disease. Microbiol Immunol. 1995;39(9):729–32.

    Article  CAS  PubMed  Google Scholar 

  22. Narikawa S, Suzuki Y, Takahashi M, Furukawa A, Sakane T, Mizushima Y. Streptococcus oralis previously identified as uncommon ‘Streptococcus sanguis’ in Behcet’s disease. Arch Oral Biol. 1995;40(8):685–90.

    Article  CAS  PubMed  Google Scholar 

  23. Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet’s disease. Cell Immunol. 1992;140(2):410–9.

    Article  CAS  PubMed  Google Scholar 

  24. Yokota K, Hayashi S, Fujii N, Yoshikawa K, Kotake S, Isogai E, et al. Antibody response to oral streptococci in Behcet’s disease. Microbiol Immunol. 1992;36(8):815–22.

    Article  CAS  PubMed  Google Scholar 

  25. Mizushima Y, Matsuda T, Hoshi K, Ohno S. Induction of Behcet’s disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol. 1988;15(6):1029–30.

    CAS  PubMed  Google Scholar 

  26. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet’s disease--a multicenter study. The Behcet’s disease research Committee of Japan. J Rheumatol. 1989;16(4):506–11.

    Google Scholar 

  27. Hugle T, Bircher A, Walker UA. Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behcet’s disease following 23-valent polysaccharide Streptococcus pneumoniae vaccine. Rheumatology (Oxford). 2012;51(4):761–2.

    Article  CAS  Google Scholar 

  28. Yoshikawa K, Kotake S, Kubota T, Kimura K, Isogai E, Fujii N. Cloning and sequencing of BeS-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behcet’s disease. Zentralbl Bakteriol. 1998;287(4):449–60.

    Article  CAS  PubMed  Google Scholar 

  29. Lehner T, Lavery E, Smith R, van der Zee R, Mizushima Y, Shinnick T. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behcet’s syndrome. Infect Immun. 1991;59(4):1434–41.

    PubMed Central  PubMed  CAS  Google Scholar 

  30. Pervin K, Childerstone A, Shinnick T, Mizushima Y, van der Zee R, Hasan A, et al. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet’s disease. J Immunol. 1993;151(4):2273–82.

    CAS  PubMed  Google Scholar 

  31. Stanford MR, Kasp E, Whiston R, Hasan A, Todryk S, Shinnick T, et al. Heat shock protein peptides reactive in patients with Behcet’s disease are uveitogenic in Lewis rats. Clin Exp Immunol. 1994;97(2):226–31.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  32. Hu W, Hasan A, Wilson A, Stanford MR, Li-Yang Y, Todryk S, et al. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol. 1998;28(8):2444–55.

    Article  CAS  PubMed  Google Scholar 

  33. Stanford M, Whittall T, Bergmeier LA, Lindblad M, Lundin S, Shinnick T, et al. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet’s disease. Clin Exp Immunol. 2004;137(1):201–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  34. Calguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet’s disease. A randomized clinical trial. Arthritis Rheum. 1996;39(12):2062–5.

    Article  CAS  PubMed  Google Scholar 

  35. Calguneri M, Ertenli I, Kiraz S, Erman M, Celik I. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet’s disease. Dermatology. 1996;192(2):125–8.

    Article  CAS  PubMed  Google Scholar 

  36. Mumcu G, Inanc N, Ozdemir FT, Tulunay A, Eksioglu-Demiralp E, Ergun T, et al. Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Behcet’s disease. Int J Dermatol. 2013;52(12):1561–6.

    Article  CAS  PubMed  Google Scholar 

  37. Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of Behcet’s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J. 1997;38(6):444–54.

    Article  CAS  PubMed  Google Scholar 

  38. Lule S, Colpak AI, Balci-Peynircioglu B, Gursoy-Ozdemir Y, Peker S, Kalyoncu U, et al. Behcet disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger. J Autoimmun. 2017;84:87–96.

    Article  CAS  PubMed  Google Scholar 

  39. Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C, et al. Behcet’s syndrome patients exhibit specific microbiome signature. Autoimmun Rev. 2015;14(4):269–76.

    Article  PubMed  Google Scholar 

  40. Shimizu J, Kubota T, Takada E, Takai K, Fujiwara N, Arimitsu N, et al. Bifidobacteria abundance-featured gut Microbiota compositional change in patients with Behcet’s disease. PLoS One. 2016;11(4):e0153746.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  41. Seoudi N, Bergmeier LA, Drobniewski F, Paster B, Fortune F. The oral mucosal and salivary microbial community of Behcet’s syndrome and recurrent aphthous stomatitis. J Oral Microbiol. 2015;7:27150.

    Article  CAS  PubMed  Google Scholar 

  42. Coit P, Mumcu G, Ture-Ozdemir F, Unal AU, Alpar U, Bostanci N, et al. Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behcet’s disease. Clin Immunol. 2016;169:28–35.

    Article  CAS  PubMed  Google Scholar 

  43. Hatemi G, Bahar H, Uysal S, Mat C, Gogus F, Masatlioglu S, et al. The pustular skin lesions in Behcet’s syndrome are not sterile. Ann Rheum Dis. 2004;63(11):1450–2.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  44. Gul A, Inanc M, Ocal L, Aral O, Konice M. Familial aggregation of Behcet’s disease in Turkey. Ann Rheum Dis. 2000;59(8):622–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  45. Gul A. Genetics of Behcet’s disease: lessons learned from genomewide association studies. Curr Opin Rheumatol. 2014;26(1):56–63.

    Article  CAS  PubMed  Google Scholar 

  46. Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease. Proc Natl Acad Sci U S A. 2013;110(20):8134–9.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Takeuchi M, Mizuki N, Meguro A, Ombrello MJ, Kirino Y, Satorius C, et al. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet’s disease susceptibility. Nat Genet. 2017;49(3):438–43.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  48. Direskeneli H, Mumcu G. A possible decline in the incidence and severity of Behcet’s disease: implications for an infectious etiology and oral health. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S86–90.

    PubMed  Google Scholar 

  49. Kirino Y, Ideguchi H, Takeno M, Suda A, Higashitani K, Kunishita Y, et al. Continuous evolution of clinical phenotype in 578 Japanese patients with Behcet’s disease: a retrospective observational study. Arthritis Res Ther. 2016;18(1):217.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmet Gül .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gül, A. (2018). Behçet Disease. In: Ragab, G., Atkinson, T., Stoll, M. (eds) The Microbiome in Rheumatic Diseases and Infection. Springer, Cham. https://doi.org/10.1007/978-3-319-79026-8_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-79026-8_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-79025-1

  • Online ISBN: 978-3-319-79026-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics